Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial-Reference-Cited by-同舟云学术

Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial

Published:2015-03 Issue:9971 Volume:385 Page:857-866
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Martinez Fernando J,Calverley Peter M A,Goehring Udo-Michael,Brose Manja,Fabbri Leonardo M,Rabe Klaus F

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary;Vestbo;Am J Respir Crit Care Med,2013

2. Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance;O'Reilly;BMJ,2010

3. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease;Calverley;N Engl J Med,2007

4. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide;Wedzicha;Am J Respir Crit Care Med,2008

5. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial;Aaron;Ann Intern Med,2007

Cited by 307 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence Following Conditional NICE Technology Appraisal Recommendations: A Critical Analysis of Methods, Quality and Risk of Bias;PharmacoEconomics;2024-09-09

2. Electrocardiographic alterations in chronic obstructive pulmonary disease;Journal of Electrocardiology;2024-07

3. Rethinking bronchiectasis as an inflammatory disease;The Lancet Respiratory Medicine;2024-07

4. Therapeutic perspectives on PDE4B inhibition in adipose tissue dysfunction and chronic liver injury;Expert Opinion on Therapeutic Targets;2024-06-19

5. Management of Refractory Chronic Obstructive Pulmonary Disease: A Review;Life;2024-04-24